Prolinx Raises $16.8M in New Financing | GenomeWeb

NEW YORK, July 17 - Prolinx has raised $16.8 million in new funding, the company announced Tuesday.

The Bothell, Wash.-based manufacturer of tools and applications for manipulating macromolecules said it would use the new funds for product releases, including a protein microarray product line and a series of molecular interaction analysis systems for label-free detection in bioresearch and drug discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.